ATLANTA — Cancer is over one hundred different diseases hiding under one name. That's why, just as there isn't one universal way to treat cancer, there also isn't one universal way to detect it. But that doesn't mean scientists aren't trying: If researchers can find a unique signature or "biomarker" of cancer — meaning a
Robert D. Schreiber, PhD, the Andrew M. and Jane M. Bursky Distinguished Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis, has been elected a fellow of the American Association for Cancer Research (AACR) Academy. The academy recognizes “distinguished scientists whose major scientific contributions have propelled significant innovation and progress
The American Association for Cancer Research (AACR) today released its annual Cancer Progress Report highlighting how federally funded research discoveries are fueling the development of new and even more effective ways to prevent, detect, diagnose, and treat cancer. Key advances outlined in the AACR Cancer Progress Report 2018 include the following: Twenty-two treatments for cancer
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok